The Budget provides proof of the United Progressive Alliance government having forgotten the importance of its own “flagship schemes”. BUDGET 2012-13 provides conclusive proof that the United Progressive Alliance (UPA) government has lost its way. It has managed the remarkable feat of upsetting almost everyone and making no one happy. The Budget is highly regressive in both taxation and spending terms and will raise prices of essentials, so aam aurat and...

The Planning Commission is back in the news. The latest round of poverty levels that have been disclosed have created another debate in the country. Once more, people are stunned at the meager rate of Rs 28 that has been defined as the poverty line. Even though I addressed some apprehensions in an earlier post, this time around the issue seems to be more about myths, perceptions and lack of...

Critics are wrong when they say poverty has not declined. However, they are right, unknowingly though, when they say that the Planning Commission has not been entirely forthcoming about how it arrived at the poverty estimates it put out last week. The commission seems to have quietly tweaked the consumption data for 2009-10 used to estimate poverty. Hence, not only has it undercounted the poor in 2009-10 by some 18 million,...

Says respond else face action Annoyed by the non-submission of reports regarding illegal clinical trials of breast cancer drug, the National Human Rights Commission (NHRC) has issued notices to the Union health ministry and the Andhra Pradesh government. It has asked the Centre and the state government to respond within six weeks or face action. The commission had in June last year sent notices to the Union health secretary, secretary of the...

India's decision this month to produce Germany-based multinational Bayer's anti-cancer drug Nexavar, in the first use of "compulsory licensing" in South Asia, will save lives but also raises intricate questions. Under the compulsory licensing process, a government can under World Trade Organization (WTO) rules bypass a patent owner's rights after three years and order the manufacture and sale of life-saving medicines at much cheaper cost than by obtaining the medicine from...